Fiberight licenses TMO cellulosic ethanol technology; aims for 15 US projects

In the UK, TMO Renewables has signed a deal with Fiberight in the US for a 20-year, $500 million deal to supply the American company with its proprietary GM bacteria used to break down MSW into biofuels. Fiberight claims that TMO’s technology is three to five years ahead of the US, while TMO claims it could supply up to 50% of the US’s second generation biofuel requirement under the RFS2.

Fiberight expects to build 15 plants in the US using TMO’s technology in the next five years.

More on the story.